BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ndadza A, Thomford NE, Mukanganyama S, Wonkam A, Ntsekhe M, Dandara C. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future. OMICS 2019;23:152-66. [PMID: 30883300 DOI: 10.1089/omi.2019.0018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Dai DP, Wu H, Chong J, Lü Y, Yin R, Zhao X, Zhao A, Yang J, Chen H. Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation. Pharmacogenomics 2020;21:1021-31. [PMID: 32893731 DOI: 10.2217/pgs-2020-0051] [Reference Citation Analysis]
2 Bentley AR, Callier SL, Rotimi CN. Evaluating the promise of inclusion of African ancestry populations in genomics. NPJ Genom Med 2020;5:5. [PMID: 32140257 DOI: 10.1038/s41525-019-0111-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
3 Dandara C, Ndadza A, Soko N. The importance of including African populations in pharmacogenetics studies of warfarin response. Pharmacogenomics 2021. [PMID: 34821506 DOI: 10.2217/pgs-2021-0142] [Reference Citation Analysis]
4 Collins JM, Wang D. Co-expression of drug metabolizing cytochrome P450 enzymes and estrogen receptor alpha (ESR1) in human liver: racial differences and the regulatory role of ESR1. Drug Metab Pers Ther 2021;36:205-14. [PMID: 33823094 DOI: 10.1515/dmpt-2020-0160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]